Scientists exploring possible link between Johnson & Johnson, AstraZeneca vaccine blood clot issues
(NEW YORK) -- With the Johnson & Johnson COVID-19 vaccine still on pause in the U.S. after reports of a rare but severe blood clotting disorder in a small number of the roughly 7 million people who've received the shot, health experts now are... Read More.
